Arcturus Therapeutics Holdings Inc. , an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States.
Arcturus Therapeutics Holdings stock last closed at $17.32, down 3.99% from the previous day, and has decreased 13.01% in one year. It has overperformed other stocks in the Biotechnology industry by 0.36 percentage points. Arcturus Therapeutics Holdings stock is currently +115.42% from its 52-week low of $8.04, and -33.08% from its 52-week high of $25.88.
As of Sep 12, 2025, there are 27.15M shares of ARCT outstanding. The market capitalization of ARCT is $470.32M. In the last 24 hours, 644,000 ARCT shares were traded.
How to Buy Arcturus Therapeutics Holdings Stock
Wondering how to invest in Arcturus Therapeutics Holdings stock? Here's how.
Choose where to buy Arcturus Therapeutics Holdings stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Arcturus Therapeutics Holdings stock.
Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Fund your investment account: Select your payment method and add your details.
Research Arcturus Therapeutics Holdings stock: The Arcturus Therapeutics Holdings ticker symbol is ARCT. Is Arcturus Therapeutics Holdings stock a good investment? Should you buy shares of ARCT? How do ARCT's underlying business fundamentals look? Do top analysts think Arcturus Therapeutics Holdings is a good buy? Why has ARCT's stock price moved recently? (Hint: Our stock research tools can help you decide if ARCT is a good stock to buy).
Make your ARCT purchase: Decide if you will purchase ARCT shares at the current market price or use a limit order to purchase ARCT stock at a particular price.
Track your investment in ARCT: Create a watchlist to keep tabs on your investment in Arcturus Therapeutics Holdings shares.
Step 1: Choose where to buy Arcturus Therapeutics Holdings stock
You need a brokerage account in order to access the NASDAQ market and buy ARCT shares.
A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best place to buy stocks. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to global financial markets: From Tech to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've chosen the best brokerage, you need to fill out some personal details so you are able to invest in ARCT today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Arcturus Therapeutics Holdings stock
After you have identified the best place to buy Arcturus Therapeutics Holdings stock, it's crucial to evaluate their stock before you buy, so you can understand the risk as well as the opportunity.
Arcturus Therapeutics Holdings shares at a glance
ARCT Price
$17.32
1w %
-2.97%
1y %
-13.01%
5y %
-57.99%
P/E
-7.77x
P/B
2.04x
P/S
3.85x
PEG
N/A
Revenue
$122.12M
Earnings
-$60.16M
Fore. Rev. Growth
38.14%
Fore. Earn. Growth
N/A
Market Cap
$470.32M
Next Earnings
Nov 5, 2025
Next Dividend
N/A
Fundamentals of ARCT
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in less time.
ARCT has cash burn of 65158000. It has enough cash and short-term investments to cover this for at least one year.
ARCT has $251.47M in cash and short term investments. This is enough to cover its annual cash burn of $65.16M.
Total ARCT debt is lower than 5 years ago, relative to shareholder equity.
ARCT has a low debt to equity ratio of 0.34.
There are more short-term assets than short-term liabilities on the ARCT balance sheet.
There are more short-term assets than long-term liabilities on the ARCT balance sheet.
Cons:
ARCT profit margin has gone down from -43.9% to -49.3% in the past year.
Is ARCT stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 7 Equities analysts who give ratings on ARCT, the consensus analyst rating on ARCT is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent ARCT Analyst Upgrades/Downgrades
Whitney Ijem, a top 6% analyst from Canaccord Genuity maintains ARCT with a strong buy rating and lowers their ARCT price target from $68.00 to $66.00, on May 13, 2025.
Ed Arce, a top 3% analyst from HC Wainwright & Co. reiterates ARCT with a buy rating and maintains their ARCT price target from $60.00 to $60.00, on Apr 10, 2025.
Last year, ARCT revenue was $122.12M. In the past 5 year, ARCT's revenue has grown by 61.1% per year. This was slower than the Biotechnology industry average of 66.52%.
No, Arcturus Therapeutics Holdings doesn't provide an income stream by paying out dividends.
ARCT Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your ARCT purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually the best for newer investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a particular price limit, use a limit order.
Hit the Open Trade button and your broker will place the order.
If you require more help investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Arcturus Therapeutics Holdings share?
As of Sep 12, 2025, it costs $17.32 to buy one share of Arcturus Therapeutics Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.462 shares of ARCT.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Is now a good time to buy Arcturus Therapeutics Holdings stock?
According to 7 Wall Street analysts who monitor Arcturus Therapeutics Holdings, their consensus recommendation is to buy Arcturus Therapeutics Holdings stock.
What is the best way to buy Arcturus Therapeutics Holdings stock?
One way to place an order for Arcturus Therapeutics Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.